BGMS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BGMS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Bio Green Med Solution Inc BGMS
Bio Green Med Solution BGMS -0.53% 47 Days Payable is 62.73 as of Mar. 2026, which is 96% below its 10-year median of 1,563.09. GuruFocus rates BGMS with a GF Score™ of 47/100 and a GF Value™ of $2.56 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 706 Biotechnology companies, Bio Green Med Solution ranks worse than 53.68% on this metric.
Bio Green Med Solution's average Accounts Payable for the three months ended in Mar. 2026 was $0.44 Mil. Bio Green Med Solution's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.64 Mil. Hence, Bio Green Med Solution's Days Payable for the three months ended in Mar. 2026 was 62.73.
The historical rank and industry rank for Bio Green Med Solution's Days Payable or its related term are showing as below:
During the past 13 years, Bio Green Med Solution's highest Days Payable was 1563.09. The lowest was 98.35. And the median was 1563.09.
Bio Green Med Solution's Days Payable increased from Mar. 2025 (0.00) to Mar. 2026 (62.73). It may suggest that Bio Green Med Solution delayed paying its suppliers.
The historical data trend for Bio Green Med Solution's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Bio Green Med Solution Annual Data | |||||||||||||||||||||
| Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | Dec25 | |||||||||||
| Days Payable | Get a 7-Day Free Trial |
|
|
0.00 | 0.00 | 0.00 | 0.00 | 1,563.09 | |||||||||||||
| Bio Green Med Solution Quarterly Data | ||||||||||||||||||||
| Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | Jun25 | Sep25 | Dec25 | Mar26 | |
| Days Payable | Get a 7-Day Free Trial |
|
|
|
|
|
|
|
|
|
|
|
|
0.00 | 0.00 | 491.18 | 90.83 | 62.73 | ||
For the Biotechnology subindustry, Bio Green Med Solution's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Bio Green Med Solution's Days Payable distribution charts can be found below:
* The bar in red indicates where Bio Green Med Solution's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bio Green Med Solution's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
| Days Payable (A: Dec. 2025 ) | |||||||||
| = | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
| = | ( (Accounts Payable (A: Dec. 2024 ) | + | Accounts Payable (A: Dec. 2025 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2025 ) | * | Days in Period |
| = | ( (4.599 | + | 0.617) | / | 2 ) | / | 0.609 | * | 365 |
| = | 2.608 | / | 0.609 | * | 365 | ||||
| = | 1,563.09 |
Bio Green Med Solution's Days Payable for the quarter that ended in Mar. 2026 is calculated as:
| Days Payable (Q: Mar. 2026 ) | |||||||||
| = | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
| = | ( (Accounts Payable (Q: Dec. 2025 ) | + | Accounts Payable (Q: Mar. 2026 )) | / | count ) | / | Cost of Goods Sold (Q: Mar. 2026 ) | * | Days in Period |
| = | ( (0.617 | + | 0.256) | / | 2 ) | / | 0.635 | * | 365 / 4 |
| = | 0.4365 | / | 0.635 | * | 365 / 4 | ||||
| = | 62.73 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Based on GuruFocus' analysis, Bio Green Med Solution stock appears to be undervalued. The current stock price of $0.60 is trading 76.5% below its estimated GF Value™ of $2.56. GuruFocus considers Bio Green Med Solution to be Possible Value Trap.
Key valuation signals for BGMS:
No single metric tells the full story. See the BGMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.